Document Detail

A model to describe myocardial drug disposition in the dog.
MedLine Citation:
PMID:  7391969     Owner:  NLM     Status:  MEDLINE    
A model, employing open-chested, anesthetized dogs, was developed to facilitate the study of myocardial drug disposition. Propranolol was employed as a model compound for initial investigation. Propranolol was administered as either a single i.v. bolus of 0.5 mg/kg or by a stepwise infusion protocol employing three rates: 2.6, 6.5 and 12.0 micrograms/kg/min. Blood and myocardial biopsy samples were obtained at specified times and the concentration of propranolol in tissue homogenates and plasma was determined by a high-pressure liquid chromotographic procedure. The concentration-time data obtained from the i.v. bolus studies were fitted to a three-compartment model where one of the compartments represented the myocardium. The model predicts that plasma and myocardial concentrations achieve distribution equilibrium within 2 min after administration. The myocardial-to-plasma concentration ratios ranged from 6.2 to 20.3 and were constant with time for each dog. The myocardial-to-plasma concentration ratios also remained constant during the infusion protocol, indicating linear accumulation up to myocardial concentrations of 6.7 micrograms/ml. To assess regional myocardial concentration differences, the concentration of drug in the right atrium was compared with the concentration of drug in the right atrium was compared with the concentration in the left ventricle at the end of the infusion protocol. The concentrations were not significantly different. The model developed will be used to study the myocardial disposition of several antiarrhythmic drugs and the factors which affect their rate and extent of accumulation.
R E Kates; P Jaillon
Related Documents :
24942899 - Splenic infarction and malaria.
7630159 - Profibrillatory effects of lidocaine in the acutely ischemic porcine heart.
2046029 - Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in ...
7786689 - A prospective randomized trial of intravenous magnesium versus intravenous propranolol ...
7391969 - A model to describe myocardial drug disposition in the dog.
2908709 - Left ventricular function and beta-blockers: does intrinsic sympathomimetic activity ha...
18627569 - Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease.
15808839 - Increased resistance to myocardial ischemia in the brown norway vs. dahl s rat: role of...
16310439 - Clinical determinants of sinus conversion by radiofrequency maze procedure for persiste...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  214     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1980 Jul 
Date Detail:
Created Date:  1980-09-26     Completed Date:  1980-09-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  31-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Injections, Intravenous
Models, Biological
Myocardium / metabolism*
Organ Size
Pharmaceutical Preparations / metabolism*
Propranolol / blood,  metabolism
Time Factors
Tissue Distribution
Reg. No./Substance:
0/Pharmaceutical Preparations; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anti-inflammatory and ulcerogenic effects and pharmacokinetics of dexamethasone in protein-deficient...
Next Document:  Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosome...